Monday, March 7, 2016

UCLA Sells Royalty Rights to Pharma for Prostate Cancer Drug

The story behind the discovery of Xtandi by Dr Saywer (Memorial Sloan) and Dr Jung (UCLA) is remarkable. I saw Dr Saywer speak at Society of Urologic Oncology meeting in Bethesda in 2008 and he spoke about the discovery of Xtandi with chemist Dr Jung. The agent had pro- and anti-androgenic properties, but eventually causes anti-androgenic outcome after some interesting physiology happens. UCLA anticipates ~$60 million annually until 2027.

Read UCLA Newsroom article for further details. 

No comments:

Post a Comment